Tag Archives: Might

How COVID-19 drug/vaccine decisions might be based on little evidence

At this point, the Food and Drug Administration could grant emergency-use authorization. In other words, the two vaccines could hinge on the combined results of 64 people. Haseltine concludes: If — or perhaps when — positive early results from these trials are announced, keep my warnings in mind. These protocols seem designed to get a… Read More »

Who should get the Covid-19 vaccine first? It’s way trickier than you might think

U.S. President Donald Trump delivers a speech during a visit to the Fujifilm Diosynth Biotechnologies’ Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. Carlos Barria | Reuters The hunt is on for a vaccine for Covid-19,… Read More »

Healthcare Might Look Good in Plaid

By KIM BELLARD I don’t really follow FinTech — I can’t even keep up with HealthTech! — but it caught my eye when Visa announced that it was acquiring FinTech company Plaid for $ 5.3b; a 2018 funding round valued the company at $ 2.65b.  A 100% increase in valuation within a year suggests that something important… Read More »